1. The plaintiffs' claims against the defendants are all dismissed.

2. The costs of lawsuit are assessed against the plaintiffs.

1. Basic facts

A. The relevant plaintiffs of the parties are co-inheritors (the shares in inheritance each 1/2) of the deceased, who are children of the deceased D (hereinafter “the deceased”), and the Defendants are the deceased and the deceased as the insured.

The insurers who have concluded the insurance contract as described in the subsection are the insurers.

B. 1) The Deceased’s New Life Insurance Co., Ltd. (hereinafter “Defendant Life Insurance Co., Ltd.”) entered into an insurance contract

A) A contractor and the insured were the deceased and entered into an insurance contract with non-negotiable accident insurance without dividends. According to the insurance contract with a specific second-party disease death agreement under the above contract, the insured shall pay KRW 10,000,000 to the beneficiary with the insurance proceeds for death with a specific second-party disease (hereinafter “first-party insurance contract”).

(1) The term “specific two diseases” in Article 12 of the Insurance Terms and Conditions is defined as follows: <1> The term “specific two diseases” in this special agreement refers to the diseases classified as “cerebral cerebrovassis” and “abscopic scopic scopic scopic scopic scopic scopic scopic scopics” in the basic classification of “the Korean Standard Industrial Classification of Diseases” (hereinafter referred to as the “specific two diseases scopic scopic sc

(3) The diagnosis and confirmation of 'patchological refluence certificate' must be conducted by a person with a medical doctor's license (excluding dentists), and this diagnosis shall be based on in-depth examination, heart heart high wave, ornamental beer (scativity), blood-centered efficacy test, and nuclear medical examination, along with medical history. However, only when the insured (person insured) dies and cannot be based on the above method of inspection, the insured (person insured) can be based on the document or evidence verifying that the person insured was diagnosed or treated with acute refluence.

Article 13. Types and amounts of insurance proceeds.